Welcome to Hologic Investor Relations

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems for breast and skeletal heath, GYN surgical products and medical aesthetic systems. With a broad range of market-leading technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol HOLX.

Recent News
May 16, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately. Mr. Dockendorff also was appointed to the...

May 10, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today the Company's financial results for the fiscal second quarter ended April 1, 2017. GAAP diluted earnings per share (EPS) of $1.84 increased 666.7%...

May 8, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences: Bank of America Merrill Lynch 2017 Health Care Conference in Las Vegas, NV on...

Apr 4, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes. In...

More ›